Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

Authors :: Gall, C.M. le
Cammarata, Anna
Haas, Lukas de
Ramos Tomillero, I.
Cuenca Escalona, J.
Schouren, K.
Wijfjes, Z.
Becker, A.M.D.
Bödder, J.
Dolen, Y.
Vries, I.J.M. de
Figdor, C.G.
Flórez-Grau, G.
Verdoes, M.
Gall, C.M. le
Cammarata, Anna
Haas, Lukas de
Ramos Tomillero, I.
Cuenca Escalona, J.
Schouren, K.
Wijfjes, Z.
Becker, A.M.D.
Bödder, J.
Dolen, Y.
Vries, I.J.M. de
Figdor, C.G.
Flórez-Grau, G.
Verdoes, M.
Source :: Journal for Immunotherapy of Cancer; 2051-1426; 4; 10; e004309; ~Journal for Immunotherapy of Cancer~~~~~2051-1426~4~10~~e004309
Publication Year :: 2022
Abstract: Contains fulltext : 249311.pdf (Publisher’s version ) (Open Access)

Database :: OAIster
Journal :: Journal for Immunotherapy of Cancer; 2051-1426; 4; 10; e004309; ~Journal for Immunotherapy of Cancer~~~~~2051-1426~4~10~~e004309
Publication Type :: Electronic Resource
Accession number :: edsoai.on1367164876
Document Type :: Electronic Resource

Tools